Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
49.66%
0%
49.66%
6 Months
80.33%
0%
80.33%
1 Year
50.68%
0%
50.68%
2 Years
3.29%
0%
3.29%
3 Years
4.76%
0%
4.76%
4 Years
-32.31%
0%
-32.31%
5 Years
-54.17%
0%
-54.17%
ECO Animal Health Group Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.02%
EBIT Growth (5y)
7.74%
EBIT to Interest (avg)
6.62
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.05
Tax Ratio
34.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.69%
ROE (avg)
6.28%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
0.72
EV to EBIT
8.78
EV to EBITDA
5.27
EV to Capital Employed
0.61
EV to Sales
0.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.95%
ROE (Latest)
3.12%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Mar'23
Mar'23
Mar'22
Change(%)
Net Sales
85.30
82.20
3.77%
Operating Profit (PBDIT) excl Other Income
7.40
6.50
13.85%
Interest
0.70
0.30
133.33%
Exceptional Items
0.00
-2.20
100.00%
Consolidate Net Profit
3.10
-0.70
542.86%
Operating Profit Margin (Excl OI)
59.30%
55.10%
0.42%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2023 is 3.77% vs -22.16% in Mar 2022
Consolidated Net Profit
YoY Growth in year ended Mar 2023 is 542.86% vs -104.43% in Mar 2022
About ECO Animal Health Group Plc 
ECO Animal Health Group Plc
Pharmaceuticals & Biotechnology
Eco Animal Health Group plc is engaged in the development, registration and marketing of pharmaceutical products for global animal health markets. The Company's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. The Company's products include Aivlosin and Ecomectin. Aivlosin is an antibiotic that treats a range of specific enteric (gut) and respiratory diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. It operates in the United Kingdom and Europe, the Far East, Latin America, North America, and the Middle East and Africa. Its subsidiaries include Eco Animal Health Limited and ECO Animal Health do Brasil Comercio de Produtos Veterinarios Ltda.
Company Coordinates 
Company Details
78 Coombe Road , NEW MALDEN None : KT3 4QS
Registrar Details






